All Blogs

Apr 02, 2020

Niacin fights Glioblastoma, iTeos nets $125M, Pandion reels in $80M, Brii, Chinese partner, FDA to speed up COVID-19 therapies


Apr 01, 2020

Telemedicine: Can it be the future of healthcare?


Mar 31, 2020

J&J’s COVID-19 Vaccine; GigaGen COVID-19 therapy; FDA approved Abbott’s POC test; Cobra Bio raises $ 3.3 M


Mar 30, 2020

Realm of Pandemics: Were we prepared then? Are we prepared now? Will we be ever prepared?


Mar 27, 2020

What is driving Retinitis pigmentosa market forward?


Mar 26, 2020

FDA permits COVID-19 treatment, Roche’s antibiotics pact, Moderna’s vaccine, FDA permits Remdesivir, ReCode needs USD 80 Million


Mar 25, 2020

Bioelectronic Medicine: Applications and Future Prospects


Mar 24, 2020

Thermo’s investment; Biohaven’s vazegepant Phase III trial; Cumberland’s aid


Mar 23, 2020

Retinitis Pigmentosa: A complex disease, and the increasing gap between prevalence and diagnosed prevalence


Mar 20, 2020

Soft Tissue Sarcoma Market size to increase with a CAGR of 6.47% – Emerging therapies and Increasing Incidence form major market drivers